These data illustrate a timeline of tumor refilling post-radiation that includes a high rate of CD8 T cell movement through the TdLN that may play a key role in antigen-guided T cell control of residual cancer cells and systemic tumor immune surveillance following radiation. The gene discussed is CD8A; the disease is neoplasm.